← Back to Clinical Trials
Recruiting NCT05140434

NCT05140434 Evaluation of the Benefit of Exercise Testing for the Diagnosis of Obstruction in the Coronary Arteries of the Heart

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05140434
Status Recruiting
Phase
Sponsor Centre Hospitalier Sud Francilien
Condition Coronary Artery Disease
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2022-05-04
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Exercise testCardiac CT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2022-05-04 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to determine whether exercise testing can detect an obstruction in a coronary artery, and, thereby, can avoid performing a coronary imaging in some cases. Patients with a suspicion of coronary artery disease perform an exercise test on an exercise bike with increasing load. EKG, blood pressure, and other parameters are monitored. Patients benefit also of either a cardiac CT scan or a coronary angiography to establish whether they really have coronary obstruction.

Eligibility Criteria

Inclusion Criteria: * Starting betweew 1/1/2019 and 3/1/2022 * 18 year-old patients or older * Patients with both exercise testing and either Cardiac CT or coronary angiography within 3 months * Patients informed and not opposing to their participation to the study Exclusion Criteria: * Patients unable to fully understand the information related to the study

Contact & Investigator

Central Contact

Olivier CHARANSONNEY, MD

✉ olivier.charansonney@chsf.fr

📞 0161697766

Principal Investigator

Olivier CHARANSONNEY, MD

PRINCIPAL INVESTIGATOR

Centre Hospitalier Sud Francilien

Frequently Asked Questions

Who can join the NCT05140434 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05140434 currently recruiting?

Yes, NCT05140434 is actively recruiting participants. Contact the research team at olivier.charansonney@chsf.fr for enrollment information.

Where is the NCT05140434 trial being conducted?

This trial is being conducted at Corbeil-Essonnes, France.

Who is sponsoring the NCT05140434 clinical trial?

NCT05140434 is sponsored by Centre Hospitalier Sud Francilien. The principal investigator is Olivier CHARANSONNEY, MD at Centre Hospitalier Sud Francilien. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology